These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8739885)

  • 1. Hemodynamic effects of renin inhibitors.
    Kleinert HD
    Am J Nephrol; 1996; 16(3):252-60. PubMed ID: 8739885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical potential of renin inhibitors and angiotensin antagonists.
    Cody RJ
    Drugs; 1994 Apr; 47(4):586-98. PubMed ID: 7516858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics and efficacy of renin inhibitors.
    Rongen GA; Lenders JW; Smits P; Thien T
    Clin Pharmacokinet; 1995 Jul; 29(1):6-14. PubMed ID: 7586899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibition.
    Kleinert HD
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):645-55. PubMed ID: 8573547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral renin inhibitors.
    Staessen JA; Li Y; Richart T
    Lancet; 2006 Oct; 368(9545):1449-56. PubMed ID: 17055947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic prospects of renin-angiotensin system inhibition.
    Corvol P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():463-70. PubMed ID: 2691125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of renin inhibitors and their application to the treatment of hypertension.
    Wood JM; Cumin F; Maibaum J
    Pharmacol Ther; 1994; 61(3):325-44. PubMed ID: 7938177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors: specific modulators of the renin-angiotensin system.
    Luther RR; Stein HH; Glassman HN; Kleinert HD
    Arzneimittelforschung; 1989 Jan; 39(1):1-5. PubMed ID: 2655608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various approaches to blockade of the renin-angiotensin system: persistent renin response.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1990 Dec; 8(7):S149-53. PubMed ID: 2095383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
    Sepehrdad R; Frishman WH; Stier CT; Sica DA
    Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.
    Neuberg GW; Kukin ML; Penn J; Medina N; Yushak M; Packer M
    Am J Cardiol; 1991 Jan; 67(1):63-6. PubMed ID: 1986506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F; Krzesinski JM; Piérard L; Scheen AJ
    Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First orally active DRI Aliskiren--a new prospect in management of hypertension and beyond.
    Sawhney JP
    Indian Heart J; 2010; 62(1):49-56. PubMed ID: 21180035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.